A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 367 participants.
Also called NCT06603571
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 367 participants
- Sponsor
- Registry
-
NCT06603571
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Argentina
- Registry status
- Completed
Technical summary
Registry record NCT06603571. Randomized; double masking; primary purpose treatment. Start 2024-09-20 (actual); primary completion 2026-07-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Condition
- Obesity
- Condition
- Overweight
- Intervention (Drug)
- LY3841136
- Intervention (Drug)
- Tirzepatide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct06603571- Content hash
b683f3afa363d099e5ed7e2994c13740a829556c79903404da305c84246ec39c